Ferdinand Rossi

2.7k total citations · 1 hit paper
29 papers, 2.2k citations indexed

About

Ferdinand Rossi is a scholar working on Gastroenterology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ferdinand Rossi has authored 29 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Gastroenterology, 9 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ferdinand Rossi's work include Gastrointestinal Tumor Research and Treatment (19 papers), Immune Cell Function and Interaction (6 papers) and Sarcoma Diagnosis and Treatment (5 papers). Ferdinand Rossi is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (19 papers), Immune Cell Function and Interaction (6 papers) and Sarcoma Diagnosis and Treatment (5 papers). Ferdinand Rossi collaborates with scholars based in United States, France and Sweden. Ferdinand Rossi's co-authors include Cristina R. Antonescu, Peter Besmer, Jamal Tazi, Ronald P. DeMatteo, Shan Zeng, Claude Brunel, Etienne Antoine, Jean‐François Riou, Vinod P. Balachandran and Michael J. Cavnar and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ferdinand Rossi

29 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido

2011 410 citations Vinod P. Balachandran, Michael J. Cavnar et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ferdinand Rossi United States	25	885	677	638	575	488	29	2.2k
Alain Moussy France	21	603 0.7×	226 0.3×	325 0.5×	727 1.3×	655 1.3×	39	2.2k
Udayan Guha United States	24	1.0k 1.2×	96 0.1×	679 1.1×	471 0.8×	118 0.2×	51	2.1k
Yakov Fellig Israel	23	934 1.1×	55 0.1×	183 0.3×	168 0.3×	191 0.4×	78	1.8k
Masanori Naito Japan	19	693 0.8×	35 0.1×	413 0.6×	205 0.4×	372 0.8×	55	1.7k
Stephen Leong United States	10	730 0.8×	47 0.1×	595 0.9×	313 0.5×	97 0.2×	28	1.4k
Dorte Linnemann Denmark	25	715 0.8×	46 0.1×	588 0.9×	301 0.5×	71 0.1×	60	1.9k
Hiroyuki Kato Japan	24	1.6k 1.8×	25 0.0×	691 1.1×	247 0.4×	169 0.3×	73	2.6k
Kotaro Horiguchi Japan	18	593 0.7×	104 0.2×	249 0.4×	83 0.1×	120 0.2×	75	1.1k
Esw Ngan Hong Kong	27	868 1.0×	67 0.1×	185 0.3×	138 0.2×	120 0.2×	62	1.9k
Holger Kissel United States	13	830 0.9×	47 0.1×	176 0.3×	61 0.1×	369 0.8×	13	1.5k

Countries citing papers authored by Ferdinand Rossi

Since Specialization

Citations

This map shows the geographic impact of Ferdinand Rossi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ferdinand Rossi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ferdinand Rossi more than expected).

Fields of papers citing papers by Ferdinand Rossi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ferdinand Rossi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ferdinand Rossi. The network helps show where Ferdinand Rossi may publish in the future.

Co-authorship network of co-authors of Ferdinand Rossi

This figure shows the co-authorship network connecting the top 25 collaborators of Ferdinand Rossi. A scholar is included among the top collaborators of Ferdinand Rossi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ferdinand Rossi. Ferdinand Rossi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rossi, Ferdinand, Mengyuan Liu, Gerardo A. Vitiello, et al.. (2023). Myosin Light-Chain Kinase Inhibition Potentiates the Antitumor Effects of Avapritinib in PDGFRA D842V -Mutant Gastrointestinal Stromal Tumor. Clinical Cancer Research. 29(11). 2144–2157. 3 indexed citations

Zhang, Jennifer Q., Benedikt Bosbach, Jennifer K. Loo, et al.. (2020). The V654A second-site KIT mutation increases tumor oncogenesis and STAT activation in a mouse model of gastrointestinal stromal tumor. Oncogene. 39(49). 7153–7165. 9 indexed citations

Medina, Benjamin D., Mengyuan Liu, Gerardo A. Vitiello, et al.. (2019). Oncogenic kinase inhibition limits Batf3-dependent dendritic cell development and antitumor immunity. The Journal of Experimental Medicine. 216(6). 1359–1376. 22 indexed citations

Zhang, Jennifer Q., Shan Zeng, Gerardo A. Vitiello, et al.. (2018). Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors. Cancer Immunology Research. 6(4). 434–447. 48 indexed citations

Vitiello, Gerardo A., Shan Zeng, Timothy G. Bowler, et al.. (2017). Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor. Clinical Cancer Research. 24(4). 972–984. 45 indexed citations

Zeng, Shan, Adrian M. Seifert, Jennifer Q. Zhang, et al.. (2017). Wnt/β-catenin Signaling Contributes to Tumor Malignancy and Is Targetable in Gastrointestinal Stromal Tumor. Molecular Cancer Therapeutics. 16(9). 1954–1966. 31 indexed citations

Bosbach, Benedikt, Ferdinand Rossi, Jennifer K. Loo, et al.. (2017). Direct engagement of the PI3K pathway by mutant KIT dominates oncogenic signaling in gastrointestinal stromal tumor. Proceedings of the National Academy of Sciences. 114(40). E8448–E8457. 37 indexed citations

Seifert, Adrian M., Shan Zeng, Jennifer Q. Zhang, et al.. (2016). PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors. Clinical Cancer Research. 23(2). 454–465. 117 indexed citations

Kim, Teresa S., Michael J. Cavnar, Noah A. Cohen, et al.. (2014). Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor. Clinical Cancer Research. 20(9). 2350–2362. 44 indexed citations

10.

Cavnar, Michael J., Shan Zeng, Teresa S. Kim, et al.. (2013). KIT oncogene inhibition drives intratumoral macrophage M2 polarization. The Journal of Experimental Medicine. 210(13). 2873–2886. 101 indexed citations

11.

Bosbach, Benedikt, Shayu Deshpande, Ferdinand Rossi, et al.. (2012). Imatinib resistance and microcytic erythrocytosis in a Kit ^{V558Δ;T669I/+} gatekeeper-mutant mouse model of gastrointestinal stromal tumor. Proceedings of the National Academy of Sciences. 109(34). E2276–83. 24 indexed citations

12.

Balachandran, Vinod P., Michael J. Cavnar, Shan Zeng, et al.. (2011). Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido. Nature Medicine. 17(9). 1094–1100. 410 indexed citations breakdown →

13.

Kwon, Joong Goo, Sung Jin Hwang, Grant W. Hennig, et al.. (2008). Changes in the Structure and Function of ICC Networks in ICC Hyperplasia and Gastrointestinal Stromal Tumors. Gastroenterology. 136(2). 630–639. 33 indexed citations

14.

Liu, Ying, Michelle Tseng, Ferdinand Rossi, et al.. (2007). Histone H2AX Is a Mediator of Gastrointestinal Stromal Tumor Cell Apoptosis following Treatment with Imatinib Mesylate. Cancer Research. 67(6). 2685–2692. 73 indexed citations

15.

Rossi, Ferdinand, Helen E. MacLean, Wei Yuan, et al.. (2002). p107 and p130 Coordinately Regulate Proliferation, Cbfa1 Expression, and Hypertrophic Differentiation during Endochondral Bone Development. Developmental Biology. 247(2). 271–285. 56 indexed citations

16.

Tazi, Jamal, et al.. (1997). DNA topoisomerase I: customs officer at the border between DNA and RNA worlds?. Journal of Molecular Medicine. 75(11-12). 786–800. 34 indexed citations

17.

Rossi, Ferdinand, Emmanuel Labourier, Thierry Forné, et al.. (1996). Specific phosphorylation of SR proteins by mammalian DNA topoisomerase I. Nature. 381(6577). 80–82. 274 indexed citations

18.

Rossi, Ferdinand, Thierry Forné, Etienne Antoine, et al.. (1996). Involvement of U1 Small Nuclear Ribonucleoproteins (snRNP) in 5′ Splice Site-U1 snRNP Interaction. Journal of Biological Chemistry. 271(39). 23985–23991. 29 indexed citations

19.

Johnson, Allan E., Sylvie Audigier, Ferdinand Rossi, et al.. (1993). Localization and characterization of vasopressin binding sites in the rat brain using an iodinated linear AVP antagonist. Brain Research. 622(1-2). 9–16. 65 indexed citations

20.

Tazi, Jamal, Ferdinand Rossi, Philippe Jeanteur, et al.. (1993). Thiophosphorylation of U1-70K protein inhibits pre-mRNA splicing. Nature. 363(6426). 283–286. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact